130 related articles for article (PubMed ID: 9655357)
1. Renal tubular function in beta-thalassemia.
Sumboonnanonda A; Malasit P; Tanphaichitr VS; Ong-ajyooth S; Sunthornchart S; Pattanakitsakul S; Petrarat S; Assateerawatt A; Vongjirad A
Pediatr Nephrol; 1998 May; 12(4):280-3. PubMed ID: 9655357
[TBL] [Abstract][Full Text] [Related]
2. Renal tubular dysfunction in alpha-thalassemia.
Sumboonnanonda A; Malasit P; Tanphaichitr VS; Ong-ajyooth S; Petrarat S; Vongjirad A
Pediatr Nephrol; 2003 Mar; 18(3):257-60. PubMed ID: 12644919
[TBL] [Abstract][Full Text] [Related]
3. Renal function in adult beta-thalassemia/Hb E disease.
Ong-ajyooth L; Malasit P; Ong-ajyooth S; Fucharoen S; Pootrakul P; Vasuvattakul S; Siritanaratkul N; Nilwarangkur S
Nephron; 1998; 78(2):156-61. PubMed ID: 9496731
[TBL] [Abstract][Full Text] [Related]
4. Renal function in children with beta-thalassemia major and thalassemia intermedia.
Smolkin V; Halevy R; Levin C; Mines M; Sakran W; Ilia K; Koren A
Pediatr Nephrol; 2008 Oct; 23(10):1847-51. PubMed ID: 18581145
[TBL] [Abstract][Full Text] [Related]
5. Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox.
Economou M; Printza N; Teli A; Tzimouli V; Tsatra I; Papachristou F; Athanassiou-Metaxa M
Acta Haematol; 2010; 123(3):148-52. PubMed ID: 20185899
[TBL] [Abstract][Full Text] [Related]
6. Urinary zinc excretion and zinc status of patients with beta-thalassemia major.
Aydinok Y; Coker C; Kavakli K; Polat A; Nisli G; Cetiner N; Kantar M; Cetingül N
Biol Trace Elem Res; 1999 Nov; 70(2):165-72. PubMed ID: 10535525
[TBL] [Abstract][Full Text] [Related]
7. Renal function in transfusion-dependent pediatric beta-thalassemia major patients.
Jalali A; Khalilian H; Ahmadzadeh A; Sarvestani S; Rahim F; Zandian K; Asar S
Hematology; 2011 Jul; 16(4):249-54. PubMed ID: 21756543
[TBL] [Abstract][Full Text] [Related]
8. Renal tubular function in children with beta-thalassemia minor.
Kalman S; Atay AA; Sakallioglu O; Ozgürtaş T; Gök F; Kurt I; Kürekçi AE; Ozcan O; Gökçay E
Nephrology (Carlton); 2005 Oct; 10(5):427-9. PubMed ID: 16221088
[TBL] [Abstract][Full Text] [Related]
9. Early markers of renal dysfunction in patients with beta-thalassemia major.
Mohkam M; Shamsian BS; Gharib A; Nariman S; Arzanian MT
Pediatr Nephrol; 2008 Jun; 23(6):971-6. PubMed ID: 18288499
[TBL] [Abstract][Full Text] [Related]
10. Renal tubule function in beta-thalassemia after hematopoietic stem cell transplantation.
Sumboonnanonda A; Sanpakit K; Piyaphanee N
Pediatr Nephrol; 2009 Jan; 24(1):183-7. PubMed ID: 18688653
[TBL] [Abstract][Full Text] [Related]
11. Renal tubular dysfunction in pediatric patients with beta-thalassemia major.
Ahmadzadeh A; Jalali A; Assar S; Khalilian H; Zandian K; Pedram M
Saudi J Kidney Dis Transpl; 2011 May; 22(3):497-500. PubMed ID: 21566307
[TBL] [Abstract][Full Text] [Related]
12. Renal tubular dysfunction with nephrocalcinosis in a patient with beta thalassemia minor.
Prabahar MR; Jain M; Chandrasekaran V; Indhumathi E; Soundararajan P
Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):964-8. PubMed ID: 18974585
[TBL] [Abstract][Full Text] [Related]
13. Renal tubular dysfunction in a patient with beta-thalassemia minor.
Oktenli C; Bulucu F
Nephron; 2002 Sep; 92(1):222-3. PubMed ID: 12187108
[TBL] [Abstract][Full Text] [Related]
14. Desferrioxamine induced urinary iron excretion in thalassemia.
Dubey AP; Kumar S; Choudhury P; Talukdar B; Puri RK
Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
[TBL] [Abstract][Full Text] [Related]
15. Major beta-thalassemia, use of desferiexamine and renal proximal tubular damage.
Jafari HM; Vahidshahi K; Kosaryan M; Karami H; Reza Mahdavi M; Ehteshami S
Bratisl Lek Listy; 2011; 112(5):278-81. PubMed ID: 21682083
[TBL] [Abstract][Full Text] [Related]
16. Early detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapy.
Cianciulli P; Sollecito D; Sorrentino F; Forte L; Gilardi E; Massa A; Papa G; Carta S
Kidney Int; 1994 Aug; 46(2):467-70. PubMed ID: 7967359
[TBL] [Abstract][Full Text] [Related]
17. Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens.
Viprakasit V; Tanphaichitr VS; Mahasandana C; Assteerawatt A; Suwantol L; Veerakul G; Kankirawatana S; Pung-Amritt P; Suvatte V
J Med Assoc Thai; 2001 Jul; 84(7):929-41. PubMed ID: 11759973
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of tubular dysfunction in pediatric patients with Beta thalassemia major receiving deferasirox.
Naderi M; Sadeghi-Bojd S; Valeshabad AK; Jahantigh A; Alizadeh S; Dorgalaleh A; Tabibian S; Bamedi T
Pediatr Hematol Oncol; 2013 Nov; 30(8):748-54. PubMed ID: 24134694
[TBL] [Abstract][Full Text] [Related]
19. Renal function in pediatric patients with beta-thalassemia major.
Aldudak B; Karabay Bayazit A; Noyan A; Ozel A; Anarat A; Sasmaz I; Kilinç Y; Gali E; Anarat R; Dikmen N
Pediatr Nephrol; 2000 Nov; 15(1-2):109-12. PubMed ID: 11095025
[TBL] [Abstract][Full Text] [Related]
20. Incidence of deferasirox-associated renal tubular dysfunction in children and young adults with beta-thalassaemia.
Dee CM; Cheuk DK; Ha SY; Chiang AK; Chan GC
Br J Haematol; 2014 Nov; 167(3):434-6. PubMed ID: 24989901
[No Abstract] [Full Text] [Related]
[Next] [New Search]
